Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.  Garrison-Desany HM, Hong X, Maher BS, Beaty TH, Wang G, Pearson C, Liang L, Wang X, Ladd-Acosta C.&nbs…

The impact of opioid exposure during pregnancy on the human neonatal immune profile.  Miller NW, Seman BG, Akers SM, Povroznik JM, Brundage K, Fang W, Robinson CM. The  Pediatr Res. 2022 Mar 14:1–9. doi: 10.1038/s41390-022-02014-x. Epub…

Use of Phenobarbital to Treat Neonatal Abstinence Syndrome From Exposure to Single vs. Multiple Substances.  Kushnir A, Garretson C, Mariappan M, Stahl G.  Front Pediatr. 2022 Jan 31;9:752854. doi: 10.3389/fped.2021.752854. PMID: 3517411…

Determination of Prenatal Substance Exposure Using Meconium and Orbitrap Mass Spectrometry.  Hernandez A, Lacroze V, Doudka N, Becam J, Pourriere-Fabiani C, Lacarelle B, Solas C, Fabresse N.  Toxics. 2022 Jan 26;10(2):55. doi: 10.3390/to…

Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.  Tang F, Ng CM, Bada HS, Leggas M.  Clin Transl Sci. 2021 Jul;14(4):1231-1249. doi: 10.1111/cts.12994. Epub 2021 May 1. PMID: 336503…

Aberrant Feeding and Growth in Neonates With Prenatal Opioid Exposure: Evidence of Neuromodulation and Behavioral Changes.  Yen E, Maron JL.  Front Pediatr. 2022 Jan 21;9:805763. doi: 10.3389/fped.2021.805763. PMID: 35127598; PMCID: PMC8…